Patents by Inventor David Herron
David Herron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20260151623Abstract: The present technology is generally directed to methods for addressing a patient's sleep apnea. At least some of the methods can include one or more of percutaneously inserting an implantable signal delivery device at an insertion point on the patient's neck, moving the signal delivery device in a medial-to-lateral direction toward an ansa cervicalis nerve of the patient, and implanting the signal delivery device at a target location at least proximate to the ansa cervicalis nerve. The signal delivery device can include at least one electrode positioned to deliver a modulation signal to tissue at least proximate to the target location, such as a portion of the ansa cervicalis nerve. In some embodiments, delivery of the modulation signal can induce caudal traction in the patient and thereby address the patient's sleep apnea.Type: ApplicationFiled: September 3, 2025Publication date: June 4, 2026Inventors: David Herron, Guillaume Raux, Timothy A. Fayram, Richard W. O'Connor
-
Patent number: 12427309Abstract: The present technology is generally directed to methods for addressing a patient's sleep apnea. At least some of the methods can include one or more of percutaneously inserting an implantable signal delivery device at an insertion point on the patient's neck, moving the signal delivery device in a medial-to-lateral direction toward an ansa cervicalis nerve of the patient, and implanting the signal delivery device at a target location at least proximate to the ansa cervicalis nerve. The signal delivery device can include at least one electrode positioned to deliver a modulation signal to tissue at least proximate to the target location, such as a portion of the ansa cervicalis nerve. In some embodiments, delivery of the modulation signal can induce caudal traction in the patient and thereby address the patient's sleep apnea.Type: GrantFiled: July 29, 2024Date of Patent: September 30, 2025Assignee: Invicta Medical, Inc.Inventors: David Herron, Guillaume Raux, Timothy A. Fayram, Richard W. O'Connor
-
Patent number: 12246175Abstract: The present technology is generally directed to methods for addressing a patient's sleep apnea. At least some of the methods can include one or more of percutaneously inserting an implantable signal delivery device at an insertion point on the patient's neck, moving the signal delivery device in a medial-to-lateral direction toward an ansa cervicalis nerve of the patient, and implanting the signal delivery device at a target location at least proximate to the ansa cervicalis nerve. The signal delivery device can include at least one electrode positioned to deliver a modulation signal to tissue at least proximate to the target location, such as a portion of the ansa cervicalis nerve. In some embodiments, delivery of the modulation signal can induce caudal traction in the patient and thereby address the patient's sleep apnea.Type: GrantFiled: March 15, 2024Date of Patent: March 11, 2025Assignee: Invicta Medical, Inc.Inventors: David Herron, Guillaume Raux, Timothy A. Fayram, Richard W. O'Connor
-
Publication number: 20250001171Abstract: The present technology is generally directed to methods for addressing a patient's sleep apnea. At least some of the methods can include one or more of percutaneously inserting an implantable signal delivery device at an insertion point on the patient's neck, moving the signal delivery device in a medial-to-lateral direction toward an ansa cervicalis nerve of the patient, and implanting the signal delivery device at a target location at least proximate to the ansa cervicalis nerve. The signal delivery device can include at least one electrode positioned to deliver a modulation signal to tissue at least proximate to the target location, such as a portion of the ansa cervicalis nerve. In some embodiments, delivery of the modulation signal can induce caudal traction in the patient and thereby address the patient's sleep apnea.Type: ApplicationFiled: July 29, 2024Publication date: January 2, 2025Inventors: David Herron, Guillaume Raux, Timothy A. Fayram, Richard W. O'Connor
-
Publication number: 20240307684Abstract: The present technology is generally directed to methods for addressing a patient's sleep apnea. At least some of the methods can include one or more of percutaneously inserting an implantable signal delivery device at an insertion point on the patient's neck, moving the signal delivery device in a medial-to-lateral direction toward an ansa cervicalis nerve of the patient, and implanting the signal delivery device at a target location at least proximate to the ansa cervicalis nerve. The signal delivery device can include at least one electrode positioned to deliver a modulation signal to tissue at least proximate to the target location, such as a portion of the ansa cervicalis nerve. In some embodiments, delivery of the modulation signal can induce caudal traction in the patient and thereby address the patient's sleep apnea.Type: ApplicationFiled: March 15, 2024Publication date: September 19, 2024Inventors: David Herron, Guillaume Raux, Timothy A. Fayram, Richard W. O'Connor
-
Publication number: 20240207613Abstract: The present technology is generally directed to systems and methods for addressing a patient's sleep apnea. At least some embodiments include an electrode array and a controller. The electrode array can include one or more electrodes and can be configured to be implanted at least proximate to a target tissue of the patient in an orientation, with at least a vector component of the orientation aligned along an inferior-superior axis of the patient. The controller can be communicatively coupled to the electrode array and include one or more non-transitory, computer-readable media having instructions that, when executed by one or more processors of the controller, cause the controller to direct an electrical signal to be delivered by the electrode array to the target tissue.Type: ApplicationFiled: December 21, 2023Publication date: June 27, 2024Inventors: Guillaume Raux, David Herron, Richard W. O'Connor, Richard Hamilton Lewis, Timothy A. Fayram
-
Patent number: 11964154Abstract: The present technology is generally directed to systems and methods for addressing a patient's sleep apnea. At least some embodiments include an electrode array and a controller. The electrode array can include one or more electrodes and can be configured to be implanted at least proximate to a target tissue of the patient in an orientation, with at least a vector component of the orientation aligned along an inferior-superior axis of the patient. The controller can be communicatively coupled to the electrode array and include one or more non-transitory, computer-readable media having instructions that, when executed by one or more processors of the controller, cause the controller to direct an electrical signal to be delivered by the electrode array to the target tissue.Type: GrantFiled: June 7, 2023Date of Patent: April 23, 2024Assignee: Invicta Medical, Inc.Inventors: Guillaume Raux, David Herron, Richard W. O'Connor, Richard Hamilton Lewis, Timothy A. Fayram
-
Publication number: 20230218892Abstract: Intraoral appliances are disclosed that provide electrical stimulation to tissue in a patient's oral cavity in a manner that reduces apnea events during sleep. A representative appliance can induce a current or currents through tissue and/or anatomical structures in a manner that maintains upper airway tone and/or patency.Type: ApplicationFiled: December 22, 2022Publication date: July 13, 2023Inventors: Walter Joseph Stevens, David Herron, Chang Yeul Lee, Ling-Kang Tong, Paul Thomas Hichwa, Hoa D. Nguyen, Nishant Srivastava, Eymard Julio Burlaza
-
Publication number: 20220409897Abstract: The present technology is generally directed to wearable devices for treating sleep apnea, and associated systems and methods. In some embodiments, a system for treating sleep apnea comprises an implantable device and a wearable device. The implantable device can be implantably positionable at a patient's head and/or neck, proximate to the patient's oral cavity, and include a signal generator configured to generate an electrical signal, an electrode coupled to the signal generator to direct the electrical signal to the patient's tissue, and a power receiver device coupled to the signal generator. The wearable device can include a power source and a power transmission device coupled to the power source and configured to transmit power wirelessly to the implantable device.Type: ApplicationFiled: June 28, 2022Publication date: December 29, 2022Inventors: Richard W. O'Connor, Timothy A. Fayram, Dennis Potts, Paul Paspa, Guillaume Raux, David Herron
-
Patent number: 11491324Abstract: Intraoral electrical stimulation devices are disclosed. A representative device, which can be used to treat sleep apnea, includes an intraoral attachment body, a guide element carried by the attachment body and having a constrained guide path, and an electrode movably supported relative to the guide element and movable along the constrained guide path to a plurality of positions. A positioning member is coupleable to the electrode to move the electrode along the constrained guide path, and a signal generator is coupleable to the electrode to direct a stimulation signal to the electrode.Type: GrantFiled: October 14, 2020Date of Patent: November 8, 2022Assignee: Invicta Medical, Inc.Inventors: David Herron, Ling-Kang Tong, Hoa D. Nguyen, Chang Yeul Lee
-
Publication number: 20210113832Abstract: Intraoral electrical stimulation devices are disclosed. A representative device, which can be used to treat sleep apnea, includes an intraoral attachment body, a guide element carried by the attachment body and having a constrained guide path, and an electrode movably supported relative to the guide element and movable along the constrained guide path to a plurality of positions. A positioning member is coupleable to the electrode to move the electrode along the constrained guide path, and a signal generator is coupleable to the electrode to direct a stimulation signal to the electrode.Type: ApplicationFiled: October 14, 2020Publication date: April 22, 2021Inventors: David Herron, Ling-Kang Tong, Hoa D. Nguyen, Chang Yeul Lee
-
Publication number: 20200376261Abstract: Intraoral appliances are disclosed that provide electrical stimulation to tissue in a patient's oral cavity in a manner that reduces apnea events during sleep. A representative appliance can induce a current or currents through tissue and/or anatomical structures in a manner that maintains upper airway tone and/or patency.Type: ApplicationFiled: March 6, 2020Publication date: December 3, 2020Inventors: Walter Joseph Stevens, David Herron, Chang Yeul Lee, Ling-Kang Tong, Paul Thomas Hichwa, Hoa D. Nguyen, Nishant Srivastava, Eymard Julio Burlaza
-
Publication number: 20070028723Abstract: The invention includes an attachment for a socket wrench that is capable of imparting torque about an axis simultaneously in opposite directions. The invention also includes a method for imparting torque about an axis simultaneously in opposite directions.Type: ApplicationFiled: August 1, 2006Publication date: February 8, 2007Inventors: Donald De Celles, David Barr, David Herron
-
Publication number: 20070027185Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.Type: ApplicationFiled: September 24, 2004Publication date: February 1, 2007Applicant: ELILILLY AND COMPANYInventors: Jeffry Franciskovich, Theodore Goodson, David Herron, Angela Marquart, John Masters, David Mendel, Leander Merritt, Andrew Ratz, Gerald Smith, Michael Wiley, Ying Yee
-
Publication number: 20050282862Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.Type: ApplicationFiled: July 29, 2003Publication date: December 22, 2005Inventors: Douglas Beight, Trelia Craft, Carl Denny, Jeffry Franciskovich, Theodore Goodson, Steven Hall, David Herron, Sajan Joseph, Valentine Klimkowski, Jeffrey Kyle, John Masters, David Mendel, Guy Milot, Marta Pineiro-Nunez, Jason Sawyer, Robert Shuman, Gerald Smith, Anne Tebbe, Jennifer Tinsley, Leonard Weir, James Wikel, Michael Wiley, Ying Yee
-
Patent number: 5172708Abstract: There is disclosed a wrapper for a smoking article, the wrapper comprising a single paper sheet. The sheet is formed from at least two webs. The webs are combined whilst at least one web is still in its wet stage of production prior to drying. Different stocks can be used to make the webs so as to impart different qualities.Type: GrantFiled: February 26, 1992Date of Patent: December 22, 1992Inventors: Christopher G. Drewett, Brian C. Chard, David Herron, Colin D. Luton
-
Patent number: 4848374Abstract: A smoking device for releasing an aerosol into the mouth of a smoker comprises in combination, a chamber into which a mixture of air and a liquid aerosol precursor is introduced, a heat source surrounding the chamber, a first duct providing communication between the chamber and a smoker's mouth, whereby the contents of the chamber may be drawn into the smoker's mouth, a container for the aerosol precursor, a second duct means leading from the aerosol precursor container into the chamber whereby aerosol precursor may pass from said container into the chamber, and a third duct means providing communication between ambient air and the chamber whereby ambient air may be drawn into the chamber by the smoker, the arrangement being such that in operation liquid aerosol precursor entering the chamber is converted into a condensation aerosol.Type: GrantFiled: June 10, 1988Date of Patent: July 18, 1989Inventors: Brian C. Chard, Christopher R. Bale, Beresford R. Gill, David Herron, Stephen J. Garrett